GlaxoSmithKline Plc has settled thousands more lawsuits brought by patients alleging its Avandia diabetes drug caused heart attacks, in a move that may defuse potentially massive claims over the medicine.
According to a Reuters report, a spokeswoman for Glaxo said that consolidated cases which had been due to come to court in Philadelphia this month had been settled.
This settlement follows a separate settlement of some 700 cases last month for about $60 million.
